Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment
The FASEB Journal · 2023
DOI: 10.1096/fj.202301343 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Xinpeng Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Science and Technology Innovation 2025 Major Project of Ningbo.
Abstract (Originalsprache)
Although the role of N6‐Methyladenosine (m6A) methylation factors has been established in multiple cancer types, its involvement in glioblastoma multiforme (GBM) remains limited. This study aims to explore the involvement of m6A regulators in GBM and examine their association with the tumor immune microenvironment (TIME). A comprehensive set of 24 candidate m6A RNA regulators was procured. Consensus clustering was performed based on these regulators to identify distinct GBM clusters. PD‐L1 and PD‐1 levels, immune cell infiltration, and immune scores were evaluated between two clusters. Prognostic signatures and correlation analysis with TIME were analyzed using Lasso and Spearman's analysis. GBM tissue was collected to verify the correlations. Eighteen m6A regulators ( WTAP , YTHDF2 , HNRNPC , CAPRIN1 , YTHDF3 , METTL14 , GNL3 , ZCCHC4 , HNRNPD , YTHDF1 , RBM15 , PCIF1, RBM27, KIAA1429, MSI2, FTO, ALKBH5 , and METTL3 ), PD‐L1 , and PD‐1 were significantly upregulated in GBM tissue. These regulators were divided into two distinct molecular subtypes (clusters 1 and 2). Cluster 2 exhibited a significant increase in immune score, monocytes, M1 macrophages, activated mast cells, and eosinophils. HNRNPC , YWHAG , and ALKBH5 were significantly associated with TIME and positively correlated with PD‐L1 . Immune cell invasiveness profiles dynamically changed with copy number changes of these three m6A regulators. Finally, YWHAG and ALKBH5 were found to be independent prognostic indicators of GBM through risk analysis and were experimentally verified with clinical samples. YWHAG and ALKBH5 may be used as prognostic markers for patients with GBM. m6A methylation regulators may play an important role in regulating PD‐L1/PD‐1 expression and immune infiltration, thus having a significant impact on GBM TIME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
- Affiliated Cixi Hospital, Wenzhou Medical University, Ningbo, China.
- Key Laboratory of Precision Medicine for Atherosclerotic Diseases of Zhejiang Province, Ningbo, China.
Förderung
- Science and Technology Innovation 2025 Major Project of Ningbo
Zitieren
APA
Deng, X., Sun, X., Hu, Z., Wu, Y., Zhou, C., Sun, J., Gao, X., & Huang, Y. (2023). Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment. The FASEB Journal. https://doi.org/10.1096/fj.202301343
Vancouver
Deng X, Sun X, Hu Z, Wu Y, Zhou C, Sun J, et al. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment. The FASEB Journal. 2023. doi:10.1096/fj.202301343
BibTeX
@article{Deng2023,
author = {Deng, Xinpeng and Sun, Xiaoke and Hu, Ziliang and Wu, Yiwen and Zhou, Chenhui and Sun, Jie and Gao, Xiang and Huang, Yi},
title = {Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202301343}
}
EUVIMED